Rafferty Asset Management, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1389426
New York, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,683,840
+$8,315,260 QoQ
Shares Held
65,798
+20.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#205
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. VRTX ranks #1 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,683,840 | 65,798 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,368,580 | 54,572 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,865,655 | 68,082 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,772,969 | 81,128 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $33,438,081 | 75,108 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,339,800 | 70,830 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $36,331,191 | 90,219 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $40,140,589 | 86,309 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $43,649,550 | 93,125 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,154,881 | 79,316 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $31,831,818 | 78,232 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,787,107 | 77,032 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $24,768,129 | 70,382 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $20,486,166 | 65,021 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $18,352,546 | 63,552 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,809,894 | 61,511 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,210,878 | 46,882 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,245,084 | 58,417 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,953,926 | 54,435 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,555,259 | 47,165 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $7,893,007 | 39,146 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $8,081,798 | 37,609 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $5,913,463 | 25,021 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,942,325 | 25,512 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,162,120 | 21,226 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,715,589 | 15,615 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||